This booklet is for men who've recently been diagnosed with prostate cancer. We explain what prostate cancer is, the tests you may have to diagnose it, and the treatment options available. It has space to record your test results, treatment options and key contacts.

Last updated: March 2014
To be reviewed March 2016

References  

  • Lifetime risk of cancer. Cancer Research UK. www.cancerresearchuk.org, accessed January 2014
  • Johns LE, Houlston RS. A systematic review and meta-analysis of familial prostate cancer risk. BJU Int 2003;91:789–94.
  • Statistic calculated by Prostate Cancer UK using the current probability method using PHE and ONS data for England and Wales.
  • Giovannucci E, Liu Y, Platz EA, et al. Risk factors for prostate cancer incidence and progression in the health professionals follow-up study. Int J Cancer 2007;121(7):1571–78.
  • Orsini N, Bellocco R, Bottai M, et al. A prospective study of lifetime physical activity and prostate cancer incidence and mortality. Br J Cancer 2009;101(11):1932–38.
  • Wiseman M. The second World Cancer Research Fund/American Institute for Cancer Research expert report. Food, nutrition, physical activity, and the prevention of cancer: a global perspective. Proc Nutr Soc 2008;67(3):253–56.
  • Ma RW, Chapman K. A systematic review of the effect of diet in prostate cancer prevention and treatment. J Hum Nutr Diet 2009;22(3):187–99.
  • Allen NE, Key TJ, Appleby PN, et al. Animal foods, protein, calcium and prostate cancer risk: the European Prospective Investigation into Cancer and Nutrition. Br J Cancer 2008;98(9):1574–81.
  • Gao X, LaValley MP, Tucker KL. Prospective studies of dairy product and calcium intakes and prostate cancer risk: A meta-analysis. J Natl Cancer Inst 2005;97(23):176877.
  • Ford D, Easton D, Stratton M, et al. Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium. Am J Hum Genet1998;62(3):676–89.
  • Burford DC, Kirby M, Austoker J. Prostate Cancer Risk Management Programme Guide No 2. Information for primary care: PSA testing in asymptomatic men. NHS Cancer Screening Programmes 2010. Available from www.cancerscreening.nhs.uk
  • Holmstrom B, Johansson M, Bergh A, et al. Prostate specific antigen for early detection of prostate cancer: longitudinal study. BMJ 2009;339:b3537.
  • Berney DM. The case for modifying the Gleason grading system. BJU Int 2007;100(4):725–26.
  • Heidenreich A, Bastian PJ, Bellmunt J, et al. Guidelines on prostate cancer. European Association of Urology, March 2013. Available at www.uroweb.org
  • National Institute for Health and Clinical Excellence (NICE). Prostate cancer: diagnosis and treatment. Clinical guideline 175. January 2014. Available from www.nice.org.uk
  • Payne H. Management of locally advanced prostate cancer. Asian J Androl 2009;11(1):81–87.
  • Warde P, Mason M, Ding K, et al. Combined androgen deprivation therapy and radiation therapy for locally advanced prostate cancer: a randomised, phase 3 trial. Lancet 2011;378(9809):2104–11.
  • Widmark A, Klepp O, Solberg A, et al. Endocrine treatment, with or without radiotherapy, in locally advanced prostate cancer (SPCG-7/SFUO-3): an open randomised phase III trial. Lancet 2009;373(9660):301–8.
  • National Institute for Health and Clinical Excellence (NICE). Low dose rate brachytherapy for localised prostate cancer. Interventional Procedure Guidance 132. 2005. Available from www.nice.org.uk
  • National Institute for Health and Clinical Excellence (NICE). High dose rate brachytherapy in combination with external-beam radiotherapy for localised prostate cancer. Interventional Procedure Guidance 174. 2006. Available from www.nice.org.uk
  • Johansson J-E, Andren O, Andersson SO. Natural history of early localised prostate cancer. JAMA 2004;291(22):2713–19.
  • Crawford ED. Understanding the epidemiology, natural history and key pathways involved in prostate cancer. Urology 2009;73(5):S4–10.
  • Mishra SI, Scherer RW, Snyder C, et al. Exercise interventions on health-related quality of life for people with cancer during active treatment. Cochrane Database Syst Rev 2012;8:CD008465.
  • Hedestig O, Sandman PO, Tomic R, Widmark A. Living after external beam radiotherapy of localized prostate cancer: a qualitative analysis of patient narratives. Cancer Nurs 2005;28(4):310–17.

Order printed copies of this publication

Before you order we would like to know who you are, and why you are ordering printed copies.

Download digital versions of this publication